ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 212 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q4 2021. The put-call ratio across all filers is 0.89 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $90,737 | -18.8% | 16,649 | 0.0% | 0.00% | – |
| Q2 2023 | $111,715 | -24.0% | 16,649 | 0.0% | 0.00% | -100.0% |
| Q1 2023 | $147,011 | +15.6% | 16,649 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $127,198 | +38.3% | 16,649 | +29.1% | 0.00% | 0.0% |
| Q3 2022 | $92,000 | -11.5% | 12,894 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $104,000 | -41.9% | 12,894 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $179,000 | -53.9% | 12,894 | -6.9% | 0.00% | -50.0% |
| Q4 2021 | $388,000 | +8.7% | 13,845 | +31.7% | 0.00% | 0.0% |
| Q3 2021 | $357,000 | -16.8% | 10,511 | +0.1% | 0.00% | 0.0% |
| Q2 2021 | $429,000 | +2.1% | 10,500 | +0.7% | 0.00% | 0.0% |
| Q1 2021 | $420,000 | -38.7% | 10,423 | -10.0% | 0.00% | -50.0% |
| Q4 2020 | $685,000 | +69.6% | 11,579 | +39.4% | 0.00% | +33.3% |
| Q3 2020 | $404,000 | +0.5% | 8,308 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $402,000 | – | 8,308 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 1,014,860 | $14,086,000 | 3.47% |
| Triatomic Management LP | 297,048 | $4,123,000 | 3.35% |
| Diametric Capital, LP | 265,000 | $3,678,000 | 2.03% |
| Matrix Capital Management Company, LP | 11,572,590 | $160,628,000 | 1.93% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $416,313,000 | 1.68% |
| TIGER MANAGEMENT L.L.C. | 589,311 | $8,180,000 | 1.35% |
| Aristotle Atlantic Partners, LLC | 759,412 | $10,541,000 | 0.65% |
| Casdin Capital, LLC | 1,000,000 | $13,880,000 | 0.62% |
| Pier Capital, LLC | 339,541 | $4,713,000 | 0.60% |
| Leeward Financial Partners, LLC | 68,504 | $951,000 | 0.59% |